{{Rsnum
|rsid=12221497
|Gene=NR1H3
|Chromosome=11
|position=47259102
|Orientation=plus
|GMAF=0.1051
|Gene_s=NR1H3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 4.4 | 22.1 | 73.5
| HCB | 0.7 | 21.2 | 78.1
| JPT | 0.0 | 18.6 | 81.4
| YRI | 0.0 | 8.8 | 91.2
| ASW | 0.0 | 8.8 | 91.2
| CHB | 0.7 | 21.2 | 78.1
| CHD | 0.0 | 18.3 | 81.7
| GIH | 5.9 | 35.6 | 58.4
| LWK | 0.0 | 10.0 | 90.0
| MEX | 0.0 | 10.3 | 89.7
| MKK | 0.6 | 15.4 | 84.0
| TSI | 2.9 | 17.6 | 79.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=22189199
|Title=Genetic variation at the SLCO1B1 gene locus and low density lipoprotein cholesterol lowering response to pravastatin in the elderly
}}

{{PMID|18209740}} Association between liver X receptor alpha gene polymorphisms and risk of metabolic syndrome in French populations.

{{PMID|19292929|OA=1
}} Functional and genetic analysis in type 2 diabetes of liver X receptor alleles--a cohort study.

{{PMID|21042792}} Genetic variation within the NR1H2 gene encoding liver X receptor beta associates with insulin secretion in subjects at increased risk for type 2 diabetes.

{{PMID|21316679}} Associations between common genetic polymorphisms in the liver X receptor alpha and its target genes with the serum HDL-cholesterol concentration in adolescents of the HELENA Study.

{{PMID|21562465|OA=1
}} Liver X receptor alpha gene polymorphisms and variable cardiovascular outcomes in patients treated with antihypertensive therapy: results from the INVEST-GENES study.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | NatGeo2}}